Evidence from the literature indicates that the variant has been implicated in head and neck squamous cell carcinoma (HNSCC) where smokers with HNSCC having the GG genotype are 20 times more likely to show p53 mutations compared to individuals with the CC genotype [36]. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.